Digital therapeutics have arrived on the healthcare scene. Before they were integrated into clinical practices such as substance use disorder and chronic disease management, each company confronted this key commercial question: What is the best way to monetize digital therapeutics? More ►
Organization of the pricing and market access function
As the pharmaceutical industry faces price pressure and a challenging payer environment, realizing the full value of a drug becomes an ever more challenging endeavor. In order to succeed in this environment, pharmaceutical executives and managers are looking to shape effective and efficient organizations. More ►
Will Pharma be “Singing the Blues” or is it just “Fake News”?
Discussions around drug pricing in the US have become increasingly intense in the past few years. In May, the White House put forward President Donald J. Trump’s Blueprint to Lower Drug Prices called “American Patients First.” If this plan breaks the mold of failed proposed changes, what could the impact be?More ►